Deutsche Bank
FENC icon

Deutsche Bank’s Fennec Pharmaceuticals FENC Stock Holding History

Deutsche Bank’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$269K Sell
25,302
-3,596
-12% -$39.5K ﹤0.01% 2943
2026
Q2 		$311K Buy
28,898
+7,696
+36% +$62.8K ﹤0.01% 3021
2026
Q1 		$130K Buy
21,202
+3,837
+22% +$29.6K ﹤0.01% 3166
2025
Q4 		$134K Buy
+17,365
New +$143K ﹤0.01% 3203
2025
Q3 		– Sell
-22,328
Closed -$185K – 3642
2025
Q2 		$185K Buy
+22,328
New +$153K ﹤0.01% 3010
2024
Q4 		– Sell
-12,313
Closed -$61.6K – 3638
2024
Q3 		$61.6K Hold
12,313
– – ﹤0.01% 3321
2024
Q2 		$75.2K Hold
12,313
– – ﹤0.01% 3211
2024
Q1 		$137K Buy
12,313
+1,002
+9% +$10.1K ﹤0.01% 3028
2023
Q4 		$127K Buy
+11,311
New +$93.7K ﹤0.01% 3114
2021
Q3 		– Sell
-3,068
Closed -$22K – 4478
2021
Q2 		$22K Sell
3,068
-12,133
-80% -$81K ﹤0.01% 4413
2021
Q1 		$95K Sell
15,201
-1,326
-8% -$10K ﹤0.01% 4004
2020
Q4 		$123K Buy
16,527
+4,302
+35% +$32.8K ﹤0.01% 3732
2020
Q3 		$74K Buy
12,225
+1,051
+9% +$7.41K ﹤0.01% 3686
2020
Q2 		$93K Buy
+11,174
New +$83.1K ﹤0.01% 3466
2020
Q1 		– Sell
-1,393
Closed -$9K – 4476
2019
Q4 		$9K Buy
+1,393
New +$7.48K ﹤0.01% 4521
2019
Q3 		– Sell
-2,810
Closed -$11K – 5003
2019
Q2 		$11K Sell
2,810
-43,331
-94% -$183K ﹤0.01% 4943
2019
Q1 		$222K Buy
46,141
+31,073
+206% +$204K ﹤0.01% 3939
2018
Q4 		$95K Sell
15,068
-11,214
-43% -$78.4K ﹤0.01% 4238
2018
Q3 		$215K Sell
26,282
-3,461
-12% -$32.1K ﹤0.01% 4204
2018
Q2 		$310K Buy
29,743
+932
+3% +$11K ﹤0.01% 4082
2018
Q1 		$348K Buy
28,811
+28,207
+4,670% +$266K ﹤0.01% 3918
2017
Q4 		$6K Buy
604
+599
+11,980% +$5.98K ﹤0.01% 4836
2017
Q3 		$0 Buy
+5
New +$58 ﹤0.01% 4939

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Sierra Summit Advisors
Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Deutsche Bank's FENC Position: Q3 2026 in Review

Deutsche Bank reduced its Fennec Pharmaceuticals (FENC) stake by 12% in Q3 2026, selling an estimated $39.5K and leaving 25,302 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Deutsche Bank first reported a position in FENC in Q3 2017 and has held it in 23 quarters since. The position peaked at $348K in Q1 2018. 34 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • Deutsche Bank held 25,302 shares of Fennec Pharmaceuticals worth $269K as of Q3 2026.
  • Deutsche Bank sold 3,596 Fennec Pharmaceuticals shares in Q3 2026, an estimated $39.5K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2943 holding.
  • Deutsche Bank first reported a position in Fennec Pharmaceuticals in Q3 2017 and has held it in 23 quarters since.
  • Deutsche Bank's Fennec Pharmaceuticals position peaked at $348K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.